About: Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.39 (+8.76%)
ANEBNASDAQAnebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc share price
ANEB price activity
Last Price
$0.390
Change (24hr)
0.03 USD (8.76%)
Volume
100
Volume (4w avg)
-
Open
$0.39
Day Range
$0.39 - $0.39
Previous Close
$0.36
Last Trade
08 Sep, 1:30 pm GMT+0
Delayed
08 Sep, 1:30 pm GMT+0
ANEB price performance
Delayed
08 Sep, 1:30 pm GMT+0
ANEB Market Signals